Stayble Therapeutics AB (publ) (STO: STABL)
Sweden
· Delayed Price · Currency is SEK 0.492
-0.033 (-6.29%)
Dec 6, 2024, 5:29 PM CET
Stayble Therapeutics AB Market Cap
Stayble Therapeutics AB has a market cap or net worth of 21.51 million as of December 9, 2024. Its market cap has increased by 133.84% in one year.
Market Cap
21.51M
Enterprise Value
18.77M
Revenue
376.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since March 9, 2020, Stayble Therapeutics AB's market cap has decreased from 66.74M to 21.51M, a decrease of -67.77%. That is a compound annual growth rate of -21.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 6, 2024 | 21.51M | 123.80% |
| Dec 29, 2023 | 9.61M | -82.65% |
| Dec 30, 2022 | 55.39M | -36.71% |
| Dec 30, 2021 | 87.51M | 28.33% |
| Dec 30, 2020 | 68.20M | 2.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,298.00B |
| Swedish Orphan Biovitrum AB (publ) | 108.32B |
| Sectra AB (publ) | 56.62B |
| Getinge AB (publ) | 46.64B |
| Camurus AB (publ) | 32.17B |
| Vitrolife AB (publ) | 29.43B |
| Medicover AB (publ) | 26.87B |
| Elekta AB (publ) | 24.01B |